Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Tiotropium in Children and Adolescents With Asthma.

Murphy KR, Chipps BE.

Ann Allergy Asthma Immunol. 2019 Dec 2. pii: S1081-1206(19)31460-7. doi: 10.1016/j.anai.2019.11.030. [Epub ahead of print]

PMID:
31805357
2.

Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma.

Chipps BE, Hirsch I, Trudo F, Alacqua M, Zangrilli JG.

Ann Allergy Asthma Immunol. 2019 Oct 15. pii: S1081-1206(19)31287-6. doi: 10.1016/j.anai.2019.10.006. [Epub ahead of print]

3.

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.

Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan AH, Kamat S, Maroni J, Rowe P, Lu Y, Amin N, Pirozzi G, Ruddy M, Graham NMH, Teper A.

J Allergy Clin Immunol Pract. 2019 Sep 12. pii: S2213-2198(19)30775-5. doi: 10.1016/j.jaip.2019.08.050. [Epub ahead of print]

4.

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.

Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, Peters AT, Pavord ID, Ford LB, Sher L, Rabe KF, Rice MS, Rowe P, Lu Y, Harel S, Jagerschmidt A, Khan AH, Kamat S, Pirozzi G, Amin N, Ruddy M, Graham NMH, Mannent LP, Teper A.

J Allergy Clin Immunol Pract. 2019 Jul 24. pii: S2213-2198(19)30633-6. doi: 10.1016/j.jaip.2019.07.016. [Epub ahead of print]

5.

Symptoms and perception of airway obstruction in asthmatic patients: Clinical implications for use of reliever medications.

Barnes PJ, Szefler SJ, Reddel HK, Chipps BE.

J Allergy Clin Immunol. 2019 Nov;144(5):1180-1186. doi: 10.1016/j.jaci.2019.06.040. Epub 2019 Jul 19.

6.

Reply.

Guilbert TW, Zeiger RS, Haselkorn T, Iqbal A, Alvarez C, Mink DR, Chipps BE, Szefler SJ.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):2102-2103. doi: 10.1016/j.jaip.2019.04.034. Epub 2019 May 20. No abstract available.

PMID:
31122886
7.

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.

Hanania NA, Chipps BE, Griffin NM, Yoo B, Iqbal A, Casale TB.

J Allergy Clin Immunol. 2019 Apr;143(4):1629-1633.e2. doi: 10.1016/j.jaci.2018.11.032. Epub 2018 Dec 18. No abstract available.

8.

Harmonization of Terminology for Tolerated and Reactive Dose in Food Allergy Immunotherapy.

Casale TB, Haselkorn T, Ciaccio CE, Sriaroon P, Chipps BE.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):389-392. doi: 10.1016/j.jaip.2018.12.008. Epub 2018 Dec 14.

9.

Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology.

Chipps BE, Ciaccio CE, Rosén K, Haselkorn T, Zigmont E, Casale TB.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):721-723.e9. doi: 10.1016/j.jaip.2018.12.009. Epub 2018 Dec 14. No abstract available.

10.

The Asthma Controller Step-down Yardstick.

Chipps BE, Bacharier LB, Murphy KR, Lang D, Farrar JR, Rank M, Oppenheimer J, Zeiger RS.

Ann Allergy Asthma Immunol. 2019 Mar;122(3):241-262.e4. doi: 10.1016/j.anai.2018.12.004. Epub 2018 Dec 12.

PMID:
30550809
11.

Racial Disparities in Asthma-Related Health Outcomes in Children with Severe/Difficult-to-Treat Asthma.

Guilbert T, Zeiger RS, Haselkorn T, Iqbal A, Alvarez C, Mink DR, Chipps BE, Szefler SJ.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):568-577. doi: 10.1016/j.jaip.2018.07.050. Epub 2018 Aug 29. Erratum in: J Allergy Clin Immunol Pract. 2019 Mar;7(3):1096.

PMID:
30172020
12.

Dose counting and use of short-acting beta-agonist inhalers in emergency department patients with asthma exacerbation.

Luthe SK, Goto T, Chipps BE, Pallin DJ, Stoyanov S, Camargo CA Jr, Hasegawa K.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):256-257.e1. doi: 10.1016/j.anai.2018.05.020. Epub 2018 May 25. No abstract available.

PMID:
29803712
13.

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study.

Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, Griffin NM, Chipps BE.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):156-164.e1. doi: 10.1016/j.jaip.2018.04.043. Epub 2018 May 22.

14.

The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma.

Chipps BE, Bacharier LB, Farrar JR, Jackson DJ, Murphy KR, Phipatanakul W, Szefler SJ, Teague WG, Zeiger RS.

Ann Allergy Asthma Immunol. 2018 Jun;120(6):559-579.e11. doi: 10.1016/j.anai.2018.04.002. Epub 2018 Apr 10.

15.

Recent advances in our understanding of the environment's role in allergy.

Dinakar C, Fineman SM, Chipps BE, Khan DA, Tilles SA.

Ann Allergy Asthma Immunol. 2018 May;120(5):465-467. doi: 10.1016/j.anai.2018.03.025. Epub 2018 Mar 22. No abstract available.

PMID:
29577979
16.

Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects: Rome, Italy/Vatican City. 27-29 April 2017.

Traina G, Valluzzi RL, Fierro V, Riccardi C, Artesani MC, De Vuono A, Fiocchi A, Martelli AG, Ríos LA, Alcocer CR, Navarrete E, Del Rio Navarro BE, Gonzalez V, Velasco B, Perez Aviles HJ, Fernandez RJ, Pozo FC, Farhan AJ, Arshad H, Hussain A, Sharikadze O, Okhotnikova O, Alcover J, Rodriguez D, Pineda F, Dalal I, Weinbrand-Goichberg J, Benor S, Rottem M, Kivity S, Sato S, Yanagida N, Ebisawa M, Umanets T, Pineda F, Antipkin Y, Barzylovich V, Lapshyn V, Umanets T, Umanets M, Yuriev S, Pineda F, Rodriguez D, Alcover J, Bekir S, Pincock T, Vieira Hernandez A, Capriles Hulett A, Sánchez Borges M, Fabiano F, Albarran C, Goyal R, Gupta S, Gaurav G, Luskin AT, Griffin NM, Wagelie-Steffen A, Trzaskoma BL, Limb SL, Busse WW, Zeiger RS, Gonzalez-Reyes E, Casale TB, Chipps BE, Sugizaki C, Goto F, Sato S, Yanagida N, Ebisawa M, Yamaide A, Mitsunaga K, Tomiita M, Hoshioka A, Shimojo N, Pop LL, Ciucǎ IM, Tǎmaş L, Lazarescu M, Pienar C, Yamaide F, Fikri B, Sato H, Shimojo N, Okishima N, Kobayashi M, Takai M, Nishigata K, Yoda R, Oana YT, Kajiwara C, Shimodaira M, Suzuki T, Iizawa H, Kamijo K, Karmakar B, Bhattacharya SG, Blohlávková S, Kopelentová E, Víšek P, Štádler J, Šetinová I, Novobílská J, Lundelin K, Salminen S, Isolauri E, Pitt T, Flanders T, Peñalver M, Martínez P, Lluch M, Malet A, Nam YH, Jin HJ, Lee SK, Kulalert P, Sritipsukho P, Pathumanond J, Baynova K, Labella M, De Aramburu T, Prados M, Haanpää L, Aarnio J, Nermes M, Af Ursin P, Kaljonen A, Isolauri E, Bala N, Bhagwat K, Hindley J, Chapman M, Baalasubramanian S, Besednjak-Kocijančič L, SenGupta K, Bhattacharya SG, Chipps BE, Antonova E, Kong AM, Iqbal A, Teague WG, Chipps BE, Antonova E, Trzaskoma B, Ortiz B, Paknis B, Iqbal A, Rosen K, Szefler S, Alblooshi A, Al-Hammadi S, Vega A, Gutiérrez-Rivas R, Alonso AM, Beitia JM, Belén Mateo M, Cárdenas R, García-Domínguez JJ, Pitchon Dos Reis R, Gonçalves Alvim C, Andrade C, Reis A, Ribeiro H, Panaitescu Bunu C, Marusciac L, Paralescu S, Tamas P, Panitescu Bunu C, Marusciac L, Paralescu S, Tamas P, Martí Guadaño E, Escobar Bolaños C, Martí José N, Pau Casanovas P, Biarnés Rib G, Castells M, de Vicente Jiménez T, Mennini M, Riccardi C, De Angelis P, Rea F, Malamisura M, Tambucci R, Fiocchi A, Dall'Oglio L, Mennini M, Del Chierico F, Napolitano T, Reddel S, Vernocchi P, D'Ambrosio A, Putignani L, Artesani MC, Dahdah L, Fierro V, Banzato C, Echeverría Zudaire LA, Plaza AM, Bosque García M, Íbero M, Mazzina O, Fierro V, Marzano V, Riccardi C, Mazzina O, Dahdah L, Mennini M, Artesani MC, Mazzina O, Pecora V, Koch P, Valluzzi RL, Fierro V, Fiocchi A, Pecora V, Valentini D, Mennini M, Dahdah L, Mazzina O, Santamaria F, Valluzzi R, Mukherjee A, Kandhare A, Bodhankar S.

World Allergy Organ J. 2017 Nov 16;10(Suppl 2):39. doi: 10.1186/s40413-017-0170-3. eCollection 2017. No abstract available.

17.

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.

Luskin AT, Chipps BE, Casale TB, Griffin NM.

Ann Allergy Asthma Immunol. 2018 May;120(5):549-550. doi: 10.1016/j.anai.2018.01.034. Epub 2018 Feb 5. No abstract available.

PMID:
29421314
18.

Recent advances in asthma.

Chipps BE, Dinakar C, Fineman SM, Tilles SA.

Ann Allergy Asthma Immunol. 2018 Feb;120(2):128-130. doi: 10.1016/j.anai.2017.12.015. No abstract available.

PMID:
29413335
19.

Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma.

Chipps BE, Newbold P, Hirsch I, Trudo F, Goldman M.

Ann Allergy Asthma Immunol. 2018 May;120(5):504-511.e4. doi: 10.1016/j.anai.2018.01.030. Epub 2018 Feb 1.

20.

Severe Asthma in Primary Care: Identification and Management.

Trevor JL, Chipps BE.

Am J Med. 2018 May;131(5):484-491. doi: 10.1016/j.amjmed.2017.12.034. Epub 2018 Mar 30. Review.

21.

Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma.

Blaiss MS, Castro M, Chipps BE, Zitt M, Panettieri RA Jr, Foggs MB.

Ann Allergy Asthma Immunol. 2017 Dec;119(6):533-540. doi: 10.1016/j.anai.2017.09.058. Epub 2017 Nov 2.

PMID:
29103801
22.

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.

Chipps BE, Zeiger RS, Luskin AT, Busse WW, Trzaskoma BL, Antonova EN, Pazwash H, Limb SL, Solari PG, Griffin NM, Casale TB.

Ann Allergy Asthma Immunol. 2017 Dec;119(6):524-532.e2. doi: 10.1016/j.anai.2017.09.056. Epub 2017 Oct 18.

23.

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.

Casale TB, Chipps BE, Rosén K, Trzaskoma B, Haselkorn T, Omachi TA, Greenberg S, Hanania NA.

Allergy. 2018 Feb;73(2):490-497. doi: 10.1111/all.13302. Epub 2017 Sep 23.

24.

Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life.

Chipps BE, Haselkorn T, Rosén K, Mink DR, Trzaskoma BL, Luskin AT.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):169-176.e2. doi: 10.1016/j.jaip.2017.05.027. Epub 2017 Aug 9.

25.

More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.

Chipps BE, Haselkorn T, Paknis B, Ortiz B, Bleecker ER, Kianifard F, Foreman AJ, Szefler SJ, Zeiger RS; Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study Group.

J Allergy Clin Immunol. 2018 May;141(5):1590-1597.e9. doi: 10.1016/j.jaci.2017.07.014. Epub 2017 Aug 7.

PMID:
28797732
26.

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.

Chipps BE, Lanier B, Milgrom H, Deschildre A, Hedlin G, Szefler SJ, Kattan M, Kianifard F, Ortiz B, Haselkorn T, Iqbal A, Rosén K, Trzaskoma B, Busse WW.

J Allergy Clin Immunol. 2017 May;139(5):1431-1444. doi: 10.1016/j.jaci.2017.03.002. Review.

27.

Biologic Therapies of Immunologic Diseases.

Chipps BE, Peters SP.

Immunol Allergy Clin North Am. 2017 May;37(2):xvii-xviii. doi: 10.1016/j.iac.2017.02.001. No abstract available.

PMID:
28366489
28.

Severe Asthma in Children.

Chipps BE, Parikh NG, Maharaj SK.

Curr Allergy Asthma Rep. 2017 Apr;17(4):21. doi: 10.1007/s11882-017-0688-z. Review.

PMID:
28353215
29.

Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma.

Chipps BE, Corren J, Israel E, Katial R, Lang DM, Panettieri RA Jr, Peters SP, Farrar JR.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):133-142.e3. doi: 10.1016/j.anai.2016.12.010. Review.

PMID:
28153079
30.

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.

Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, Jacobs JS, Kraft M, Martin RJ, Nair P, Wechsler ME.

J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2S):S1-S14. doi: 10.1016/j.jaip.2016.11.029. Epub 2017 Jan 29. Review.

PMID:
28143691
31.

Clinical Tools to Assess Asthma Control in Children.

Dinakar C, Chipps BE; SECTION ON ALLERGY AND IMMUNOLOGY; SECTION ON PEDIATRIC PULMONOLOGY AND SLEEP MEDICINE.

Pediatrics. 2017 Jan;139(1). pii: e20163438. doi: 10.1542/peds.2016-3438. Review.

32.

A randomized multicenter study evaluating Xolair persistence of response after long-term therapy.

Ledford D, Busse W, Trzaskoma B, Omachi TA, Rosén K, Chipps BE, Luskin AT, Solari PG.

J Allergy Clin Immunol. 2017 Jul;140(1):162-169.e2. doi: 10.1016/j.jaci.2016.08.054. Epub 2016 Nov 5.

33.

Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma.

Tashkin DP, Moore GE, Trudo F, DePietro M, Chipps BE.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):705-12. doi: 10.1016/j.jaip.2016.02.014. Epub 2016 Mar 30.

34.

Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma.

Tran TN, Zeiger RS, Peters SP, Colice G, Newbold P, Goldman M, Chipps BE.

Ann Allergy Asthma Immunol. 2016 Jan;116(1):37-42. doi: 10.1016/j.anai.2015.10.027.

PMID:
26707771
35.

Bronchial thermoplasty: a review of the evidence.

Wilhelm CP, Chipps BE.

Ann Allergy Asthma Immunol. 2016 Feb;116(2):92-8. doi: 10.1016/j.anai.2015.11.002. Epub 2015 Dec 2. Review. No abstract available.

PMID:
26654482
36.

Update on the utility of corticosteroids in acute pediatric respiratory disorders.

Beigelman A, Chipps BE, Bacharier LB.

Allergy Asthma Proc. 2015 Sep-Oct;36(5):332-8. doi: 10.2500/aap.2015.36.3865. Review.

37.

The Bela Schick Lecture: if you don't know where you are going, you may end up somewhere else.

Chipps BE.

Ann Allergy Asthma Immunol. 2015 Jun;114(6):440-2. doi: 10.1016/j.anai.2015.03.023. Epub 2015 Apr 18. No abstract available.

PMID:
25900018
38.

Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

Chipps BE.

Pediatrics. 2014 Nov;134 Suppl 3:S182. doi: 10.1542/peds.2014-1817GGGG. No abstract available.

PMID:
25363992
39.

Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma.

Luskin AT, Chipps BE, Rasouliyan L, Miller DP, Haselkorn T, Dorenbaum A.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):544-52.e1-2. doi: 10.1016/j.jaip.2014.02.011. Epub 2014 Jul 3.

PMID:
25213047
40.

Fractional exhaled nitric oxide of at least 100 ppb and implications for future asthma research.

Chipps BE, Anderson CT, Harder JM.

Ann Allergy Asthma Immunol. 2014 Jul;113(1):118-9. doi: 10.1016/j.anai.2014.05.005. No abstract available.

PMID:
24950849
41.

Test for respiratory and asthma control in kids (TRACK): a validated control tool for preschool-aged children.

Chipps BE, Mellon MM, Murphy KR, Zeiger RS.

J Allergy Clin Immunol. 2014 Jun;133(6):1776. doi: 10.1016/j.jaci.2014.03.012. Epub 2014 Apr 29. No abstract available.

PMID:
24786240
42.

Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses.

Tashkin DP, Chipps BE, Trudo F, Zangrilli JG.

J Asthma. 2014 Aug;51(6):603-9. doi: 10.3109/02770903.2014.895012. Epub 2014 Mar 19.

43.

Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma.

Schatz M, Hsu JW, Zeiger RS, Chen W, Dorenbaum A, Chipps BE, Haselkorn T.

J Allergy Clin Immunol. 2014 Jun;133(6):1549-56. doi: 10.1016/j.jaci.2013.10.006. Epub 2013 Dec 4.

PMID:
24315502
44.

Update in pediatric anaphylaxis: a systematic review.

Chipps BE.

Clin Pediatr (Phila). 2013 May;52(5):451-61. doi: 10.1177/0009922812474683. Epub 2013 Feb 7. Review.

PMID:
23393309
45.

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort.

Chipps BE, Zeiger RS, Dorenbaum A, Borish L, Wenzel SE, Miller DP, Hayden ML, Bleecker ER, Simons FE, Szefler SJ, Weiss ST, Haselkorn T; TENOR Study Group.

Curr Respir Care Rep. 2012 Dec;1(4):259-269. Epub 2012 Sep 20.

46.

Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.

Chipps BE, Figliomeni M, Spector S.

Allergy Asthma Proc. 2012 Sep-Oct;33(5):377-85. doi: 10.2500/aap.2012.33.3599.

PMID:
23026179
47.

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.

Chipps BE, Zeiger RS, Borish L, Wenzel SE, Yegin A, Hayden ML, Miller DP, Bleecker ER, Simons FE, Szefler SJ, Weiss ST, Haselkorn T; TENOR Study Group.

J Allergy Clin Immunol. 2012 Aug;130(2):332-42.e10. doi: 10.1016/j.jaci.2012.04.014. Epub 2012 Jun 12.

48.

Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.

Zeiger RS, Yegin A, Simons FE, Haselkorn T, Rasouliyan L, Szefler SJ, Chipps BE; TENOR Study Group.

Ann Allergy Asthma Immunol. 2012 Feb;108(2):81-7. doi: 10.1016/j.anai.2011.12.001.

PMID:
22289725
49.

Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto Rico.

Carr WW, Bernstein DI, Hampel FC, Gow JA, Williams JI, Zuraw BL, Chipps BE, Miller TA, Berger WE, Carr WW, Tort MJ.

Am J Rhinol Allergy. 2011 Sep 1;25(5):369. doi: 10.2500/ajra.2011.11.3699.

PMID:
29021069
50.

Novel epinephrine auto-injector (NEA): sharps injury prevention validation and comparable analysis with EpiPen and Twinject.

Chipps BE.

Ann Allergy Asthma Immunol. 2011 Sep;107(3):286; author reply 286-7. doi: 10.1016/j.anai.2011.04.007. Epub 2011 May 10. No abstract available.

PMID:
21875554

Supplemental Content

Loading ...
Support Center